Successful use of a second course of caplacizumab in relapsed thrombotic thrombocytopenic purpura
There is limited data on the use of caplacizumab beyond the initial treatment course. We describe a patient case demonstrating the efficacy of a second course of caplacizumab in a patient with relapsed acquired thrombotic thrombocytopenic purpura (TTP). A 25-year-old female was treated for an initia...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2022-07-01
|
| Col·lecció: | Platelets |
| Matèries: | |
| Accés en línia: | http://dx.doi.org/10.1080/09537104.2021.1981851 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|